Mucosal Melanoma
📧 Sign up to get email alerts when something new happens for Mucosal Melanoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-04-23Clinical Trial Update: Stereotactic Radiosurgery and Immune Checkpoint Inhibitors With NovoTTF-200M for the Treatment of Melanoma Brain Metastases [Phase 1]
Phase 1 trial evaluating stereotactic radiosurgery, NovoTTF-200M, and immune checkpoint inhibitors for melanoma brain metastases was termina…
-
CLINICAL_TRIALS trial_result · 2026-04-02Clinical Trial Update: Proof of Concept of TBio-4101, Lymphodepleting Chemo, IL-2 for Relapsed/Refractory Melanoma [Phase 1]
Phase 1 trial update reports proof of concept for TBio-4101 in combination with lymphodepleting chemotherapy and IL-2 for relapsed/refractor…
-
CLINICAL_TRIALS trial_result · 2026-04-01Clinical Trial Update: The Value of [18F]FDG PET/CT Imaging in Prognostic Evaluation of Mucosal Melanoma
The study evaluates the prognostic value of [18F]FDG PET/CT imaging in mucosal melanoma.
-
CLINICAL_TRIALS trial_result · 2026-03-09Clinical Trial Update: Pembrolizumab and Stereotactic Radiosurgery for Melanoma or Non-Small Cell Lung Cancer Brain Metastases [Phase 1]
This phase 1 study assessed pembrolizumab in combination with stereotactic radiosurgery for patients with brain metastases from melanoma or …
-
CLINICAL_TRIALS trial_result · 2026-02-10Clinical Trial Update: Sintilimab Combined With Chemotherapy for Adjuvant Treatment of Mucosal Melanoma After Surgery [Phase 2]
Phase 2 trial evaluating sintilimab in combination with chemotherapy as adjuvant treatment for mucosal melanoma after surgery; recruitment i…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2026-01-28Clinical Trial Update: Modified Virus VSV-IFNbetaTYRP1 in Treating Patients With Stage III-IV Melanoma [Phase 1]
Phase 1 trial of the modified virus VSV-IFNbetaTYRP1 in stage III-IV melanoma was terminated.
-
CLINICAL_TRIALS trial_result · 2025-06-10Clinical Trial Update: Nemvaleukin Alfa Monotherapy and in Combination With Pembrolizumab in Patients With Advanced Cutaneous or Mucosal Melanoma - ARTISTRY-6 [Phase 2]
The ARTISTRY-6 Phase 2 trial evaluating nemvaleukin alfa as monotherapy and in combination with pembrolizumab in patients with advanced cuta…
-
CLINICAL_TRIALS trial_result · 2025-04-02Clinical Trial Update: Antitumor Activity of Vactosertib in Combination With Pembrolizumab in Acral and Mucosal Melanoma Patients Progressed From Prior Immune Check Point Inhibitor [Phase 2]
A Phase 2 trial evaluating the combination of Vactosertib and Pembrolizumab in acral and mucosal melanoma patients who progressed on prior i…
-
CLINICAL_TRIALS trial_result · 2025-01-06Clinical Trial Update: A Study to Assess YH003 in Combination with Pebolizumab and Albumin Paclitaxel Injection in Subjects with Unresectable/metastatic Mucosal Melanoma [Phase 2]
A Phase 2 trial evaluating YH003 in combination with Pebolizumab and albumin paclitaxel for unresectable/metastatic mucosal melanoma has com…
-
CLINICAL_TRIALS trial_result · 2024-11-05Clinical Trial Update: Hepatic Ablation of Melanoma Metastases to Enhance Immunotherapy Response, a Phase I Clinical Trial (HAMMER I) [Phase 1]
HAMMER I is a Phase I trial evaluating hepatic ablation of melanoma liver metastases to enhance response to immunotherapy; the study status …
-
CLINICAL_TRIALS trial_result · 2024-10-24Clinical Trial Update: Atezolizumab in Combination With Bevacizumab in Patients With Unresectable Locally Advanced or Metastatic Mucosal Melanoma [Phase 2]
Phase 2 trial of atezolizumab plus bevacizumab in unresectable mucosal melanoma completed with results posted.
-
CLINICAL_TRIALS trial_result · 2024-08-27Clinical Trial Update: Physician/Patient Choice of Either High-Dose Recombinant Interferon Alfa-2B or Ipilimumab, Versus Pembrolizumab in Treating Patients With Stage III-IV High Risk Melanoma That Has Been Removed by Surgery [Phase 3]
A Phase 3 trial comparing high-dose recombinant interferon alfa-2B or ipilimumab to pembrolizumab in patients with surgically removed stage …
-
CLINICAL_TRIALS trial_result · 2024-08-22Clinical Trial Update: Molecular Characterization of Primary Mucosal Melanoma
This clinical trial update reports molecular characterization of primary mucosal melanoma and notes the study has completed.
-
CLINICAL_TRIALS trial_result · 2024-04-05Clinical Trial Update: Neoadjuvant and Adjuvant Checkpoint Blockade [Phase 2]
A Phase 2 neoadjuvant and adjuvant checkpoint blockade trial in melanoma completed with results posted in 2024.
-
CLINICAL_TRIALS trial_result · 2024-04-04Clinical Trial Update: A Biomarker Study in Advanced Mucosal or Acral Lentiginous Melanoma Receiving Nivolumab in Combination With Ipilimumab [Phase 2]
Phase 2 trial studying nivolumab plus ipilimumab in advanced acral lentiginous melanoma and mucosal melanoma; terminated with posted results…
-
CLINICAL_TRIALS trial_result · 2023-11-21Clinical Trial Update: A Study to Compare the Administration of Pembrolizumab After Surgery Versus Administration Both Before and After Surgery for High-Risk Melanoma [Phase 2]
Phase 2 trial evaluating the timing of pembrolizumab around surgery in high-risk melanoma, comparing post-operative administration to strate…
-
CLINICAL_TRIALS trial_result · 2023-11-03Clinical Trial Update: Phase I/II Trial of a Long Peptide Vaccine (LPV7) Plus TLR Agonists [Phase 1, Phase 2]
Phase I/II trial evaluating LPV7 vaccine with TLR agonists in melanoma showed completed status with posted results.
-
CLINICAL_TRIALS trial_result · 2023-09-18Clinical Trial Update: Envafolimab Combined With Recombinant Human Endostatin and First-line Chemotherapy Treat of Advanced Mucosal Melanoma [Phase 2]
A Phase 2 clinical trial evaluating envafolimab combined with recombinant human endostatin and first-line chemotherapy for advanced mucosal …
-
CLINICAL_TRIALS trial_result · 2023-05-01Clinical Trial Update: Testing Treatment With Ipilimumab and Nivolumab Compared to Treatment With Ipilimumab Alone in Advanced Melanoma [Phase 2]
A Phase 2 study compares the combination of ipilimumab and nivolumab versus ipilimumab alone in advanced melanoma, with results posted.
-
CLINICAL_TRIALS trial_result · 2022-12-09Clinical Trial Update: Ipilimumab and Nivolumab as Adjuvant Treatment of Mucosal Melanoma [Phase 2]
A Phase 2 trial assessing the combination of ipilimumab and nivolumab as adjuvant treatment for mucosal melanoma is listed as active but not…
-
CLINICAL_TRIALS trial_result · 2022-01-31Clinical Trial Update: Toripalimab in Combination With Axitinib in Patients With Localized Mucosal Melanoma [Phase 2]
Phase 2 trial investigating toripalimab in combination with axitinib for localized mucosal melanoma is ongoing, with status currently unknow…
-
CLINICAL_TRIALS trial_result · 2022-01-25Clinical Trial Update: Postoperative Adjuvant Treatment of Completely Resected Mucosal Melanoma Phase II Study [Phase 2]
Phase II study update on postoperative adjuvant treatment for completely resected mucosal melanoma.
-
CLINICAL_TRIALS trial_result · 2020-11-13Clinical Trial Update: Lenvatinib and Pembrolizumab in Resectable Mucosal Melanoma [Phase 2]
Phase 2 trial update of lenvatinib plus pembrolizumab for neoadjuvant treatment in resectable mucosal melanoma.
-
CLINICAL_TRIALS trial_result · 2020-09-30Clinical Trial Update: The Study of JS001 Compared to High-Dose Interferon In Patients With Mucosal Melanoma That Has Been Removed by Surgery [Phase 2]
Phase 2 clinical trial update comparing JS001 to high-dose interferon in patients with mucosal melanoma that has been surgically removed.
-
CLINICAL_TRIALS trial_result · 2020-07-15Clinical Trial Update: Maintenance Treatment of Toripalimab(JS001) in Patients With Unresectable Locally Advanced or Metastatic Mucosal Melanoma [Phase 2]
Phase 2 trial update on maintenance treatment with toripalimab (JS001) in unresectable locally advanced or metastatic mucosal melanoma.